Skip to main content

Table 4 Inter-observer agreement analysis of tumor maximum width measurements

From: Prospective intra/inter-observer evaluation of pre-brachytherapy cervical cancer tumor width measured in TRUS and MR imaging

 

HRCVTMR

HRCTVTRUS

ICC

CI 95%

ICC

CI 95%

All stages

0.92

[0.89–0.94]

0.86

[0.81–0.9]

FIGO I

0.87

[0.75–0.94]

0.88

[0.76–0.95]

FIGO II

0.81

[0.74–0.87]

0.79

[0.7–0.86]

FIGO III

0.88

[0.75–0.96]

0.69

[0.42–0.87]

FIGO IV

0.93

[0.83–0.98]

0.62

[0.26–0.87]

  1. Note that: ICC > 0,75: excellent agreement; 0,4 – 0,75: fair to good agreement; < 0,4: poor agreement
  2. Abbreviations: HRCTVMR High risk clinical target volume maximum width measured at preBT MR, HRCTVTRUS Tumor maximum width measured at preBT TRUS, ICC Intra-class Correlation Coefficient, CI Confidence interval, FIGO International Federation of Gynaecology and Obstetrics
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us